Skip to main content

Advertisement

SpringerLink
Log in

EVER2 Deficiency is Associated with Mild T-cell Abnormalities

  • Original Research
  • Published:
Journal of Clinical Immunology Aims and scope Submit manuscript

Abstract

Epidermodysplasia verruciformis (EV) is a rare genodermatosis characterized by persistent flat warts or pityriasis versicolor-like lesions caused by betapapillomaviruses (EV-HPVs). Autosomal recessive EVER1 and EVER2 deficiencies account for EV in most patients. The mechanisms by which mutations in these partners of the Zinc transporter ZnT1 impair host defense against EV-HPVs are still poorly understood. Keratinocytes of EVER-deficient patients display an alteration of zinc homeostasis and an enhanced proliferative activity. Since EVER proteins are highly expressed in T lymphocytes, we aimed to assess the impact of EVER2 deficiency on T-cell development and function. We studied circulating lymphocyte populations in three adult EV patients sharing the same EVER2 mutation (T150fsX3). We found a normal count of CD4+ and CD8+ T cells and a normal proliferative capacity in response to anti-CD3 stimulation. However, we observed a significant increase of memory CD4+ and effector memory CD8+ T cells, a bias of the TCR Vαβ and Vγδ repertoires and an increase of skin-homing CD4+ T-cell subsets. Our findings suggest that EVER2-deficient patients display mild T-cell abnormalities. It remains unclear whether these abnormalities result from EVER deficiency, chronic EV-HPV infection, or both.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Orth G. Host defenses against human papillomaviruses: lessons from epidermodysplasia verruciformis. Curr Top Microbiol Immunol. 2008;321:59–83.

    Article  PubMed  CAS  Google Scholar 

  2. Lutzner MA. Epidermodysplasia verruciformis. An autosomal recessive disease characterized by viral warts and skin cancer. A model for viral oncogenesis. Bull Cancer. 1978;65(2):169–82.

    PubMed  CAS  Google Scholar 

  3. Orth G. Genetics of epidermodysplasia verruciformis: Insights into host defense against papillomaviruses. Semin Immunol. 2006;18(6):362–74.

    Article  PubMed  CAS  Google Scholar 

  4. Prawer SE, Pass F, Vance JC, Greenberg LJ, Yunis EJ, Zelickson AS. Depressed immune function in epidermodysplasia verruciformis. Arch Dermatol. 1977;113(4):495–9.

    Article  PubMed  CAS  Google Scholar 

  5. Glinski W, Jablonska S, Langner A, Obalek S, Haftek M, Proniewska M. Cell-mediated immunity in epidermodysplasia verruciformis. Dermatologica. 1976;153(4):218–27.

    Article  PubMed  CAS  Google Scholar 

  6. Glinski W, Obalek S, Jablonska S, Orth G. T cell defect in patients with epidermodysplasia verruciformis due to human papillomavirus type 3 and 5. Dermatologica. 1981;162(3):141–7.

    Article  PubMed  CAS  Google Scholar 

  7. Majewski S, Skopinska-Rozewska E, Jablonska S, Wasik M, Misiewicz J, Orth G. Partial defects of cell-mediated immunity in patients with epidermodysplasia verruciformis. J Am Acad Dermatol. 1986;15(5 Pt 1):966–73.

    Article  PubMed  CAS  Google Scholar 

  8. Pereira de Oliveira WR, Carrasco S, Neto CF, Rady P, Tyring SK. Nonspecific cell-mediated immunity in patients with epidermodysplasia verruciformis. J Dermatol. 2003;30(3):203–9.

    PubMed  Google Scholar 

  9. Majewski S, Malejczyk J, Jablonska S, Misiewicz J, Rudnicka L, Obalek S, et al. Natural cell-mediated cytotoxicity against various target cells in patients with epidermodysplasia verruciformis. J Am Acad Dermatol. 1990;22(3):423–7.

    Article  PubMed  CAS  Google Scholar 

  10. Kaminski M, Pawinska M, Jablonska S, Szmurlo A, Majewski S, Orth G. Increased natural killer cell activity in patients with epidermodysplasia verruciformis. Arch Dermatol. 1985;121(1):84–6.

    Article  PubMed  CAS  Google Scholar 

  11. Ramoz N, Rueda LA, Bouadjar B, Montoya LS, Orth G, Favre M. Mutations in two adjacent novel genes are associated with epidermodysplasia verruciformis. Nat Genet. 2002;32(4):579–81.

    Article  PubMed  CAS  Google Scholar 

  12. Casanova JL, Abel L. Primary immunodeficiencies: a field in its infancy. Science. 2007;317(5838):617–9.

    Article  PubMed  CAS  Google Scholar 

  13. Alcais A, Quintana-Murci L, Thaler DS, Schurr E, Abel L, Casanova JL. Life-threatening infectious diseases of childhood: single-gene inborn errors of immunity? Ann N Y Acad Sci. 2010;1214:18–33.

    Article  PubMed  Google Scholar 

  14. Lazarczyk M, Pons C, Mendoza JA, Cassonnet P, Jacob Y, Favre M. Regulation of cellular zinc balance as a potential mechanism of EVER-mediated protection against pathogenesis by cutaneous oncogenic human papillomaviruses. J Exp Med. 2008;205(1):35–42.

    Article  PubMed  CAS  Google Scholar 

  15. Landini MM, Zavattaro E, Borgogna C, Azzimonti B, De Andrea M, Colombo E, et al. Lack of EVER2 protein in two epidermodysplasia verruciformis patients with skin cancer presenting previously unreported homozygous genetic deletions in the EVER2 gene. J Invest Dermatol. 2012;132(4):1305–8.

    Article  PubMed  CAS  Google Scholar 

  16. Keresztes G, Mutai H, Heller S. TMC and EVER genes belong to a larger novel family, the TMC gene family encoding transmembrane proteins. BMC Genomics. 2003;4(1):24.

    Article  PubMed  Google Scholar 

  17. Haase H, Rink L. Functional significance of zinc-related signaling pathways in immune cells. Annu Rev Nutr. 2009;29:133–52.

    Article  PubMed  CAS  Google Scholar 

  18. Yu M, Lee WW, Tomar D, Pryshchep S, Czesnikiewicz-Guzik M, Lamar DL, et al. Regulation of T cell receptor signaling by activation-induced zinc influx. J Exp Med. 2011;208(4):775–85.

    Article  PubMed  CAS  Google Scholar 

  19. Lazarczyk M, Dalard C, Hayder M, Dupre L, Pignolet B, Majewski S, et al. EVER proteins, key elements of the natural anti-human papillomavirus barrier, are regulated upon T-cell activation. PLoS One. 2012;7(6):e39995.

    Article  PubMed  CAS  Google Scholar 

  20. Crequer A, Troeger A, Patin E, Ma CS, Picard C, Pedergnagna V, et al. Human RHOH deficiency causes T cell defects and susceptibility to EV-HPV infections. J Clin Invest. 2012;In press.

  21. Crequer A, Picard C, Patin E, D'Amico A, Abhyankar A, Munzer M, Debre M, de Saint-Basile G, Fischer A, Abel L, Orth G, Casanova J.-L., Jouanguy E. Inherited MST1 deficiency underlies susceptibility to EV-HPV infections. In revision Plos one. 2012;In press.

  22. Jablonska S, Dabrowski J, Jakubowicz K. Epidermodysplasia verruciformis as a model in studies on the role of papovaviruses in oncogenesis. Cancer Res. 1972;32(3):583–9.

    PubMed  CAS  Google Scholar 

  23. Clark RA, Chong B, Mirchandani N, Brinster NK, Yamanaka K, Dowgiert RK, et al. The vast majority of CLA + T cells are resident in normal skin. J Immunol. 2006;176(7):4431–9.

    PubMed  CAS  Google Scholar 

  24. Nestle FO, Di Meglio P, Qin JZ, Nickoloff BJ. Skin immune sentinels in health and disease. Nat Rev Immunol. 2009;9(10):679–91.

    PubMed  CAS  Google Scholar 

  25. Pauls K, Schon M, Kubitza RC, Homey B, Wiesenborn A, Lehmann P, et al. Role of integrin alphaE(CD103)beta7 for tissue-specific epidermal localization of CD8+ T lymphocytes. J Invest Dermatol. 2001;117(3):569–75.

    Article  PubMed  CAS  Google Scholar 

  26. Aochi S, Nakanishi G, Suzuki N, Setsu N, Suzuki D, Aya K, et al. A novel homozygous mutation of the EVER1/TMC6 gene in a Japanese patient with epidermodysplasia verruciformis. Br J Dermatol. 2007;157(6):1265–6.

    Article  PubMed  CAS  Google Scholar 

  27. Nehme NT, Pachlopnik Schmid J, Debeurme F, Andre-Schmutz I, Lim A, Nitschke P, et al. MST1 mutations in autosomal recessive primary immunodeficiency characterized by defective naive T cells survival. Blood. 2011.

  28. Abdollahpour H, Appaswamy G, Kotlarz D, Diestelhorst J, Beier R, Schaffer AA, et al. The phenotype of human STK4 deficiency. Blood. 2012.

  29. Wherry EJ. T cell exhaustion. Nat Immunol. 2011;12(6):492–9.

    Article  PubMed  CAS  Google Scholar 

  30. Randall KL, Chan SS, Ma CS, Fung I, Mei Y, Yabas M, et al. DOCK8 deficiency impairs CD8 T cell survival and function in humans and mice. J Exp Med. 2011;208(11):2305–20.

    Article  PubMed  CAS  Google Scholar 

  31. Soler D, Humphreys TL, Spinola SM, Campbell JJ. CCR4 versus CCR10 in human cutaneous TH lymphocyte trafficking. Blood. 2003;101(5):1677–82.

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgments

We thank the members of both branches of the Saint Giles Laboratory of Human Genetics of Infectious Diseases, but also Aminata Diabate, Corinne Jacques, Chantal Harre and Stephanie N’Daga for excellent technical assistance, and Svetlana Mazel for flow cytometry expertise. We warmly thank the patients for their participation. This work was supported by grants from INSERM, University Paris Descartes, the Rockefeller University, the St. Giles Foundation, and the Rockefeller University Center for Clinical and Translational Science grant number UL1RR024143.

Competing interest statement

The authors declare that they have no competing financial interests.

Author information

Authors and Affiliations

  1. St. Giles Laboratory of Human Genetics of Infectious Diseases, Rockefeller Branch, The Rockefeller University, New York, NY, USA

    Amandine Crequer, Shen-Ying Zhang, Laurent Abel, Jean-Laurent Casanova & Emmanuelle Jouanguy

  2. Laboratory of Human Genetics of Infectious Diseases, Necker Branch, INSERM U980, Paris, France

    Capucine Picard, Vincent Pedergnana, Shen-Ying Zhang, Laurent Abel, Jean-Laurent Casanova & Emmanuelle Jouanguy

  3. Study Center of Primary Immunodeficiencies, Necker Hospital, AP-HP, Paris, France

    Capucine Picard

  4. Paris Descartes University, Sorbonne Paris Cite, Paris, France

    Amandine Crequer, Capucine Picard, Vincent Pedergnana, Laurent Abel, Jean-Laurent Casanova & Emmanuelle Jouanguy

  5. Department of Immunology, Pasteur Institute, Paris, France

    Annick Lim

  6. Department of Dermatology and Venereology, Center of Diagnostics and Treatment of STD at Warsaw Medical University, Warsaw, Poland

    Slawomir Majewski

  7. Pediatric Immuno-hematology Unit, Necker Hospital, AP-HP, Paris, France

    Jean-Laurent Casanova

  8. Department of Dermatology, Warsaw School of Medecine, Warsaw, Poland

    Stefania Jablonska

  9. Department of Virology, Pasteur Institute, Paris, France

    Gerard Orth

Authors
  1. Amandine Crequer
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Capucine Picard
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Vincent Pedergnana
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Annick Lim
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Shen-Ying Zhang
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Laurent Abel
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Slawomir Majewski
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Jean-Laurent Casanova
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Stefania Jablonska
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. Gerard Orth
    View author publications

    You can also search for this author in PubMed Google Scholar

  11. Emmanuelle Jouanguy
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Emmanuelle Jouanguy.

Additional information

Amandine Crequer and Capucine Picard contributed equally to this work.

Electronic supplementary materials

Below is the link to the electronic supplementary material.

Esm 1

EVER2-deficient patients have an increase of CCR10+CD4+ T cells. Skin-homing T-cell subsets were assessed on live CD3+-gated cryopreserved PBMCs from the two patients (P1 values indicated by gray diamonds, P2 values indicated by gray squares, P3 values indicated by gray up triangles) and healthy controls (indicated by black circles) by flow cytometry (a) CCR6+, (b) CCR4+ and (c) CCR10+ proportions were assessed on live CD3+, CD4+ and CD8+ gated PBMCs for the patients and 17, 12 and 12 healthy controls, respectively. (* = p <0.05; ns = non significant). (JPEG 50 kb)

High resolution image (TIFF 1.03 MB)

Esm 2

EVER2-deficient patients have normal frequencies of αE+, α4+ and β7+ T cells. Tissue-homing T-cell subsets were assessed on live CD3+-gated cryopreserved PBMCs from the two patients (P1 values indicated by gray diamonds, P2 values indicated by gray squares, P3 values indicated by gray up triangles) and healthy controls (indicated by black circles) by flow cytometry (a) αE+, (b) αE+CLA+ proportions were assessed on live CD3+, CD4+ and CD8+ gated PBMCs and 12, 17 and 12 healthy controls, respectively (c) α4+, β7+ and α4+β7+ proportions were assessed on live CD3+ gated PBMCs for the patients and 12 healthy controls, respectively. ns = non significant). (JPEG 52 kb)

High resolution image (TIFF 0.99 MB)

Rights and permissions

Reprints and permissions

About this article

Cite this article

Crequer, A., Picard, C., Pedergnana, V. et al. EVER2 Deficiency is Associated with Mild T-cell Abnormalities. J Clin Immunol 33, 14–21 (2013). https://doi.org/10.1007/s10875-012-9749-1

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10875-012-9749-1

Keywords

Search

Navigation